Biondo Investment Advisors LLC Sells 25 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

Biondo Investment Advisors LLC decreased its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Rating) by 2.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 880 shares of the biopharmaceutical company’s stock after selling 25 shares during […]

Related Keywords

Canada ,Marion Mccourt ,Michaels Brown ,James Investment Research Inc ,Securities Exchange Commission ,Wells Fargo Company ,Quarter For Regeneron Pharmaceuticals ,Trifecta Capital Advisors ,Royal Bank ,News Ratings For Regeneron Pharmaceuticals Daily ,Biondo Investment Advisors ,Nasdaq ,Regeneron Pharmaceuticals Inc ,Minichmacgregor Wealth Management ,Regeneron Pharmaceuticals Stock Down ,Regeneron Pharmaceuticals ,Jpmorgan Chase Co ,Carolinas Wealth Consulting ,Exchange Commission ,Regeneron Pharmaceuticals Profile ,Get Rating ,Investment Advisors ,Capital Advisors ,Macgregor Wealth Management ,Wealth Consulting ,James Investment Research ,Director Michael ,Pharmaceuticals Stock Down ,Regeneron Pharmaceuticals Daily ,Nasdaq Regn ,Regn ,Medical ,75886f10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,